Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather E Olson

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Epilepsia|January 21, 2020
Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohortAnne Rochtus, Heather E Olson, Lacey Smith, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 4, 2024
Modification of a parent-report sleep scale for individuals with CDKL5 deficiency disorder: a psychometric studyJacinta M Saldaris, Scott Demarest, Peter Jacoby, et al.
The Lancet. Neurology|April 16, 2022
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trialElia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, et al.
Brain and Behavior|November 14, 2025
Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency DisorderPeter Jacoby, Eric D Marsh, Scott Demarest, et al.
Pediatric Neurology|November 20, 2022
Genetic Diagnosis Impacts Medical Management for Pediatric EpilepsiesIsabel Haviland, Carolyn I Daniels, Caitlin A Greene, et al.
Journal of Child Neurology|August 11, 2021
Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency DisorderJacinta Saldaris, Judith Weisenberg, Elia Pestana-Knight, et al.
Stem Cell Research|March 13, 2021
Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 Deficiency Disorder (CDD)Pin-Fang Chen, Teresa Chen, Taylor E Forman, et al.
Epilepsia|August 27, 2024
Psychometric evaluation of clinician- and caregiver-reported clinical severity assessments for individuals with CDKL5 deficiency disorderJacinta M Saldaris, Peter Jacoby, Jenny Downs, et al.
American Journal of Medical Genetics. Part A|June 11, 2016
BRAT1 mutations present with a spectrum of clinical severitySiddharth Srivastava, Heather E Olson, Julie S Cohen, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Epilepsia|January 21, 2020
Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohortAnne Rochtus, Heather E Olson, Lacey Smith, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 4, 2024
Modification of a parent-report sleep scale for individuals with CDKL5 deficiency disorder: a psychometric studyJacinta M Saldaris, Scott Demarest, Peter Jacoby, et al.
The Lancet. Neurology|April 16, 2022
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trialElia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, et al.
Brain and Behavior|November 14, 2025
Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency DisorderPeter Jacoby, Eric D Marsh, Scott Demarest, et al.
Pediatric Neurology|November 20, 2022
Genetic Diagnosis Impacts Medical Management for Pediatric EpilepsiesIsabel Haviland, Carolyn I Daniels, Caitlin A Greene, et al.
Journal of Child Neurology|August 11, 2021
Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency DisorderJacinta Saldaris, Judith Weisenberg, Elia Pestana-Knight, et al.
Stem Cell Research|March 13, 2021
Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 Deficiency Disorder (CDD)Pin-Fang Chen, Teresa Chen, Taylor E Forman, et al.
Epilepsia|August 27, 2024
Psychometric evaluation of clinician- and caregiver-reported clinical severity assessments for individuals with CDKL5 deficiency disorderJacinta M Saldaris, Peter Jacoby, Jenny Downs, et al.
American Journal of Medical Genetics. Part A|June 11, 2016
BRAT1 mutations present with a spectrum of clinical severitySiddharth Srivastava, Heather E Olson, Julie S Cohen, et al.
Pageof 5